CIBUS INC Stock Price, News & Analysis

Cibus (Nasdaq: CBUS) announced on November 11, 2025 the election of Craig Wichner to its Board of Directors. Mr. Wichner will also serve on the Board’s Strategy Committee as Cibus prepares for anticipated commercial scaling of its gene-edited trait platform.

Wichner is founder and managing partner of Farmland LP, which manages more than $350 million in assets and over 19,000 acres, and brings experience in regenerative and organic farming, technology, real estate investment, and agribusiness development.

Cibus (Nasdaq: CBUS) will report third quarter 2025 financial results on Thursday, November 13, 2025 after the market close. Management will host a conference call and audio webcast at 4:30 p.m. ET to discuss results and company updates.

Dial-in participant numbers are +1-800-274-8461 (U.S.) and +1-203-518-9814 (International); the conference ID is “CIBUS” or 24287. A live webcast with accompanying slides will be available at investor.cibus.com/events. A replay will be available through Thursday, November 27, 2025, and the archived webcast will remain on the company website for 90 days after the event.

Cibus (Nasdaq: CBUS) announced a collaboration with AgVayā on October 16, 2025 to accelerate introduction of Cibus’ gene-editing technologies into India’s rice seed industry.

The agreement covers market strategy, stakeholder partnerships, and R&D and commercial collaborations aimed at developing resilient, high-yield rice varieties and advanced herbicide and sustainability traits. Cibus said the work could shorten breeding timelines in India by more than a decade, improve access to modern seed technologies, and help reduce pesticide dependence.

Cibus (NASDAQ:CBUS) has announced successful field trial results for its second-generation herbicide tolerance (HT2) edited Canola trait. The trials, conducted at multiple US locations during the 2025 growing season, validated the trait's performance under real-world conditions following positive greenhouse trials.

The HT2 trait offers enhanced weed management capabilities, allowing for fewer herbicide applications and compatibility with other herbicide resistance traits. This development demonstrates the effectiveness of Cibus' Rapid Trait Development System™ (RTDS®), which significantly reduces trait development time compared to conventional breeding or GMO approaches.

Cibus (Nasdaq: CBUS), an agricultural technology company focused on developing advanced plant traits, has announced the election of Kimberly A. Box to its Board of Directors. Box brings significant leadership experience from her roles as former CEO of Gatekeeper Innovation and VP of Global IT Services at Hewlett-Packard.

Box's appointment comes at a strategic time as Cibus prepares for the launch of its trait products. Her expertise in technology commercialization and scaling businesses will support the company's mission to improve farming productivity and sustainability. She currently serves on several boards including McGrath RentCorp and holds various certifications including NACD Directorship Certification™ and CERT in Cybersecurity Oversight.

Cibus (Nasdaq: CBUS), a leading agricultural technology company focused on gene-edited plant traits, announced that its Co-Founder, President, and Interim CEO Peter Beetham will participate in a panel discussion during UN Climate Week 2025 in New York City.

The panel, titled "Biotech Meet Bytes: Innovation and Policy Pathways for Resilient Futures," will explore how biotechnology, AI, and emerging technologies can enhance resilience in food, water, and energy systems. The session will take place on September 23rd at 3:35pm ET at Midtown Loft, with other panelists from UNDP and the World Bank.

Cibus (NASDAQ:CBUS), an agricultural technology company, has entered into a material transfer agreement with Centro Internacional de Agricultura Tropical (CIAT) to introduce its proprietary HT3 clethodim herbicide tolerance trait into elite rice germplasm for Latin America. The collaboration involves the Latin American Fund for Irrigated Rice (FLAR) and the Hybrid Rice Consortium for Latin America (HIAAL).

The agreement aims to develop high-performance rice hybrids with advanced weed control technology. Cibus' HT3 trait has shown strong performance in U.S. multi-location field trials across multiple seasons. The technology addresses challenges posed by herbicide-resistant weeds, including weedy rice, while supporting the development of climate-resilient, high-yielding rice varieties.

Cibus (NASDAQ:CBUS) reported Q2 2025 financial results and provided significant business updates. The company is streamlining operations to focus on Rice herbicide tolerance traits and partner-funded programs, aiming to reduce annual cash usage to $30 million by 2026.

Key developments include: commercialization of Rice herbicide tolerance traits HT1 and HT3 targeting Latin America launch in 2027 and U.S. expansion in 2028, with potential annual royalties exceeding $200 million; a new collaboration with Colombian Rice producer Semillano; and progress in sustainable ingredients programs expected to generate initial revenues in 2025.

Financial highlights: Q2 net loss of $26.6 million ($0.61 per share), cash position of $36.5 million, and successful completion of a $27.5 million public offering. The company expects current cash to fund operations into Q2 2026.

Cibus (Nasdaq: CBUS), an agricultural technology company specializing in plant trait development and licensing, has scheduled its second quarter 2025 financial results announcement for August 14, 2025, after market close.

The company will host a conference call and audio webcast at 4:30 p.m. ET the same day. Investors can access the call using U.S. dial-in (+1-833-316-2483) or International dial-in (+1-785-838-9284) with conference ID "CIBUS" or 24287. A replay will be available until August 28, 2025. The webcast and slides will be accessible through the investor section of Cibus' website for 90 days after the event.